Kalaris Therapeutics Appoints Liisa Bayko as Chief Financial Officer
Position
Chief Financial Officer
Company
Kalaris Therapeutics
Berkeley HeightsBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaDescription
Kalaris Therapeutics has announced the appointment of Liisa Bayko as the new chief financial officer (CFO). With over two decades of experience in biotechnology finance and strategy, Bayko is expected to significantly contribute to Kalaris' mission.
Quick answer
Kalaris Therapeutics Appoints Liisa Bayko as Chief Financial Officer (July 20, 2026). Kalaris Therapeutics is based in Berkeley Heights, New Jersey, United States.
- Who is the new Chief Financial Officer at Kalaris Therapeutics?
- Kalaris Therapeutics named Liisa Bayko Chief Financial Officer, announced July 20, 2026.
- What did Kalaris Therapeutics announce on July 20, 2026?
- Kalaris Therapeutics has announced the appointment of Liisa Bayko as the new chief financial officer (CFO). With over two decades of experience in biotechnology finance and strategy, Bayko is expected to significantly contribute to Kalaris' mission.
- Where did Liisa Bayko work before joining Kalaris Therapeutics?
- Liisa Bayko joins from Evercore ISI.
- What does Kalaris Therapeutics do?
- Kalaris Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development and commercialization of treatments for prevalent retinal diseases with major unmet medical needs.
- Where is Kalaris Therapeutics based?
- Kalaris Therapeutics is based in Berkeley Heights, New Jersey, United States.
- Which similar companies made leadership changes around the same time?
- Verdiva Bio (July 23, 2026), Tarsus Pharmaceuticals (July 13, 2026), Foresee Pharmaceuticals (July 9, 2026) and Acadia Pharmaceuticals (July 6, 2026) also announced leadership changes within 45 days of Kalaris Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Verdiva Bio Appoints New Chief Medical Officer (July 23, 2026)
- Tarsus Pharmaceuticals Appoints Neera Clase as Interim Chief Commercial Officer (July 13, 2026)
- Foresee Pharmaceuticals Appoints Brian J. Groch as Chief Commercial Officer (July 9, 2026)
- Acadia Pharmaceuticals Appoints Carl Segerstrom as Chief People Officer (July 6, 2026)
- PeptiDream Appoints Catherine Ohura and Jun Kono to Executive Vice President Positions (July 2, 2026)
- Nurix Therapeutics Appoints Wes Burwell as Chief Human Resources Officer (August 21, 2026)
Who to call at Kalaris Therapeutics, and when
A new leader at Kalaris Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Kalaris Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Kalaris Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Kalaris Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Kalaris Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Kalaris Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.